Search
for
Sort by
Research 241–270 of 583
- Application of Baricitinib in Dermatology
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Molecular docking studies and ADME-Tox prediction of phytocompounds from Merremia peltata as a potential anti-alopecia treatment
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Drivers of plateau adaptability in cashmere goats revealed by genomic and transcriptomic analyses
- Baricitinib for the Treatment of Alopecia Areata
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Janus kinase inhibitors for alopecia areata: A narrative review
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Canonical prolactin signaling and global mRNA expression in the skin of Holstein heifers carrying the SLICK1 allele of the prolactin receptor gene
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients